ArticleTranslational lung cancer research2025
Electromagnetic navigation bronchoscopy for localization of bilateral multiple pulmonary nodules: a comparative evaluation of safety and efficacy.
Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Initial experience with the EndoFusion 3D system for noninvasive intraoperative localization of pulmonary nodules.Journal of thoracic disease · 2026Article
- The unified front: a multidisciplinary approach in the Era of uniportal thoracic surgery.Frontiers in surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer frequently presents with bilateral multiple pulmonary nodules (BMPNs), whose accurate intraoperative localization during surgery is challenging, making reliable preoperative localization essential. This retrospective study evaluates the safety and efficacy of electromagnetic navigation bronchoscopy-guided dye marking (ENBDM) compared with conventional computed tomography-guided percutaneous dye marking (CTPDM) for localizing BMPNs. Methods: A retrospective cohort study was conducted on patients with BMPNs who underwent preoperative localization (either ENBDM or CTPDM) followed by video-assisted thoracoscopic surgery (VATS) between January 2020 and September 2024. Patients' characteristics, nodule features, localization procedural details, procedure-related complications, pain scores, and surgical outcomes were compared between the two groups. Results: A total of 150 patients were evaluated, including 79 patients who underwent ENBDM for preoperative pulmonary nodule localization and 71 patients who underwent CTPDM. Compared to the computed tomography (CT) group, the ENB group localized smaller nodules {6 [interquartile range (IQR), 5-8] Conclusions: For patients with BMPNs, ENB-guided localization achieved comparable accuracy to CT-guided localization, while offering significantly shorter localization times and a complete absence of complications. ENBDM represents a safe, efficient, and reliable method for preoperative localization of BMPNs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.